
Sarah James
Stock Analyst at Cantor Fitzgerald
(4.26)
# 1,474
Out of 5,162 analysts
514
Total ratings
58%
Success rate
5.5%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Reiterated: Buy | $8 | $3.11 | +157.23% | 2 | Nov 16, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Buy | $5 → $2 | $0.5329 | +275.30% | 3 | Nov 13, 2026 | |
| NPCE NeuroPace | Reiterated: Buy | $21 → $12 | $8.14 | +47.42% | 3 | Nov 13, 2026 | |
| UHS Universal Health Services | Reiterated: Hold | n/a | $174.98 | - | 38 | Nov 11, 2026 | |
| HUM Humana | Reiterated: Buy | $460 → $495 | $380.00 | +30.26% | 41 | Nov 6, 2026 | |
| ACHC Acadia Healthcare Company | Reiterated: Hold | $30 → $39 | $34.47 | +13.14% | 18 | Nov 5, 2026 | |
| CI The Cigna Group | Reiterated: Buy | $340 | $273.04 | +24.52% | 29 | Nov 5, 2026 | |
| PGNY Progyny | Reiterated: Buy | $31 → $35 | $35.45 | -1.27% | 15 | Nov 5, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $80 → $92 | $59.61 | +54.34% | 2 | Nov 2, 2026 | |
| TDOC Teladoc Health | Reiterated: Buy | $10 | $7.79 | +28.37% | 9 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $79 | $65.58 | +20.46% | 59 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $24 | $26.69 | -11.95% | 11 | Oct 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $209 | $203.34 | +2.78% | 43 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $1.60 | +840.44% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 | $263.59 | -7.05% | 29 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $525 | $460.33 | +14.05% | 35 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 → $110 | $80.04 | +37.43% | 23 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $450 | $390.16 | +15.34% | 29 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.1716 | +1,648.25% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $1.29 | +132.56% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.2301 | +2,942.16% | 1 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $440 | $330.48 | +33.14% | 45 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $28 | $17.59 | n/a | 3 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $8.91 | n/a | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $5 | $10.70 | n/a | 3 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $128 → $103 | $156.34 | n/a | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $57 | $28.68 | n/a | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $56 → $76 | $132.28 | n/a | 13 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $5.35 | n/a | 1 | Jun 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 → $80 | $84.80 | n/a | 7 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3 | $1.61 | n/a | 12 | Aug 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $290 | $407.24 | n/a | 1 | Oct 19, 2017 |
MiMedx Group
Nov 16, 2026
Reiterated: Buy
Price Target: $8
Current: $3.11
Upside: +157.23%
CVRx, Inc.
Nov 13, 2026
Reiterated: Buy
Price Target: $5 → $2
Current: $0.5329
Upside: +275.30%
NeuroPace
Nov 13, 2026
Reiterated: Buy
Price Target: $21 → $12
Current: $8.14
Upside: +47.42%
Universal Health Services
Nov 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $174.98
Upside: -
Humana
Nov 6, 2026
Reiterated: Buy
Price Target: $460 → $495
Current: $380.00
Upside: +30.26%
Acadia Healthcare Company
Nov 5, 2026
Reiterated: Hold
Price Target: $30 → $39
Current: $34.47
Upside: +13.14%
The Cigna Group
Nov 5, 2026
Reiterated: Buy
Price Target: $340
Current: $273.04
Upside: +24.52%
Progyny
Nov 5, 2026
Reiterated: Buy
Price Target: $31 → $35
Current: $35.45
Upside: -1.27%
Tempus AI
Nov 2, 2026
Reiterated: Buy
Price Target: $80 → $92
Current: $59.61
Upside: +54.34%
Teladoc Health
Oct 28, 2026
Reiterated: Buy
Price Target: $10
Current: $7.79
Upside: +28.37%
Oct 27, 2026
Reiterated: Buy
Price Target: $75 → $79
Current: $65.58
Upside: +20.46%
Oct 26, 2026
Downgraded: Hold
Price Target: $18 → $24
Current: $26.69
Upside: -11.95%
Oct 21, 2026
Reiterated: Hold
Price Target: $209
Current: $203.34
Upside: +2.78%
Aug 5, 2026
Reiterated: Buy
Price Target: $15
Current: $1.60
Upside: +840.44%
Jul 23, 2026
Reiterated: Buy
Price Target: $245
Current: $263.59
Upside: -7.05%
Jul 14, 2026
Reiterated: Buy
Price Target: $525
Current: $460.33
Upside: +14.05%
Jul 7, 2026
Reiterated: Buy
Price Target: $95 → $110
Current: $80.04
Upside: +37.43%
Jul 7, 2026
Reiterated: Buy
Price Target: $400 → $450
Current: $390.16
Upside: +15.34%
May 8, 2026
Reiterated: Buy
Price Target: $3
Current: $0.1716
Upside: +1,648.25%
May 8, 2026
Reiterated: Hold
Price Target: $3
Current: $1.29
Upside: +132.56%
Apr 20, 2026
Reiterated: Buy
Price Target: $7
Current: $0.2301
Upside: +2,942.16%
Jan 28, 2026
Reiterated: Buy
Price Target: $440
Current: $330.48
Upside: +33.14%
Jun 13, 2025
Reiterated: Buy
Price Target: $33 → $28
Current: $17.59
Upside: n/a
Sep 15, 2022
Reiterated: Hold
Price Target: $6 → $5
Current: $8.91
Upside: n/a
Aug 19, 2022
Reiterated: Buy
Price Target: $7 → $5
Current: $10.70
Upside: n/a
Aug 16, 2022
Reiterated: Hold
Price Target: $128 → $103
Current: $156.34
Upside: n/a
Aug 5, 2022
Reiterated: Hold
Price Target: $50 → $57
Current: $28.68
Upside: n/a
Nov 23, 2020
Upgraded: Buy
Price Target: $56 → $76
Current: $132.28
Upside: n/a
Jun 15, 2020
Initiated Coverage: Buy
Price Target: $32
Current: $5.35
Upside: n/a
Nov 11, 2019
Reiterated: Buy
Price Target: $96 → $80
Current: $84.80
Upside: n/a
Aug 7, 2019
Reiterated: Sell
Price Target: $4 → $3
Current: $1.61
Upside: n/a
Oct 19, 2017
Reiterated: Hold
Price Target: $290
Current: $407.24
Upside: n/a